drugset / Trial / NCT00319215
Effects of Ramelteon on Driving Ability
RandomizedCrossoverDouble-blindPrevention
Summary
The primary purpose of this study is to investigate the effects of bedtime administration of a single dose of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on next-morning on-road driving performance. In addition, the drugs' effects on balance are evaluated during the night, and the next morning residual effects on memory and psychomotor performance.
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2006-07
Outcome
Missed primary endpoint
paper SDLP was significantly increased after the intake of ramelteon (+2.2 cm) and zopiclone (+2.9 cm). PMID 21966064 ↗
paper Ramelteon (8 mg) and zopiclone (7.5 mg) significantly impaired driving performance, cognitive, memory, and psychomotor performance the morning following bedtime administration. PMID 21966064 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | — |
| Subject | Zopiclone | Small molecule | 7.5 mg | — |